Mimicking of Arginine by Functionalized N(ω)-Carbamoylated Arginine As a New Broadly Applicable Approach to Labeled Bioactive Peptides: High Affinity Angiotensin, Neuropeptide Y, Neuropeptide FF, and Neurotensin Receptor Ligands As Examples

J Med Chem. 2016 Mar 10;59(5):1925-45. doi: 10.1021/acs.jmedchem.5b01495. Epub 2016 Feb 11.

Abstract

Derivatization of biologically active peptides by conjugation with fluorophores or radionuclide-bearing moieties is an effective and commonly used approach to prepare molecular tools and diagnostic agents. Whereas lysine, cysteine, and N-terminal amino acids have been mostly used for peptide conjugation, we describe a new, widely applicable approach to peptide conjugation based on the nonclassical bioisosteric replacement of the guanidine group in arginine by a functionalized carbamoylguanidine moiety. Four arginine-containing peptide receptor ligands (angiotensin II, neurotensin(8-13), an analogue of the C-terminal pentapeptide of neuropeptide Y, and a neuropeptide FF analogue) were subject of this proof-of-concept study. The N(ω)-carbamoylated arginines, bearing spacers with a terminal amino group, were incorporated into the peptides by standard Fmoc solid phase peptide synthesis. The synthesized chemically stable peptide derivatives showed high receptor affinities with Ki values in the low nanomolar range, even when bulky fluorophores had been attached. Two new tritiated tracers for angiotensin and neurotensin receptors are described.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Angiotensin II / chemistry
  • Angiotensin II / pharmacology*
  • Arginine / analogs & derivatives*
  • Arginine / chemistry
  • Cells, Cultured
  • Dose-Response Relationship, Drug
  • Humans
  • Ligands
  • Molecular Structure
  • Neuropeptide Y / chemistry
  • Neuropeptide Y / pharmacology*
  • Neurotensin / chemistry
  • Neurotensin / pharmacology*
  • Oligopeptides / chemistry
  • Oligopeptides / pharmacology*
  • Peptide Fragments / chemistry
  • Peptide Fragments / pharmacology*
  • Receptors, Angiotensin / metabolism*
  • Receptors, Neuropeptide / agonists
  • Receptors, Neuropeptide / metabolism*
  • Receptors, Neurotensin / antagonists & inhibitors
  • Receptors, Neurotensin / metabolism*
  • Structure-Activity Relationship

Substances

  • Ligands
  • Neuropeptide Y
  • Oligopeptides
  • Peptide Fragments
  • Receptors, Angiotensin
  • Receptors, Neuropeptide
  • Receptors, Neurotensin
  • Angiotensin II
  • Neurotensin
  • neurotensin (8-13)
  • Arginine
  • phenylalanyl-leucyl-phenylalanyl-glutaminyl-prolyl-glutaminyl-arginyl-phenylalaninamide